Covaxin Efficacy Yet to be Reviewed by Govt, Bharat Biotech to Submit Data in 2-3 Days: Report

Bharat Biotech, which developed the drug that has shown an efficacy of 81% in the initial phase 3 trial analysis, would submit the clinical trial data to the government in the coming days for review, said a senior official at CDSCO, which is under the Drugs Controller General of India (DCGA).

from Top India News-
Read The Rest:news18..